STOCK TITAN
  1. Home
  2. Sec-filings
  3. MDT
  4. [Form 4] Medtronic plc Insider Trading Activity

Medtronic (NYSE: MDT) EVP settles performance share units into ordinary shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Medtronic plc executive Harry "Skip" Kiil increased his direct Medtronic shareholding through equity compensation. On May 26, 2026, he acquired 15,195 Ordinary Shares, representing shares issued upon settlement of previously granted performance-vesting share units. These awards were granted on July 31, 2023, vested on April 24, 2026, and were settled after performance was certified on May 26, 2026. Following the transaction, Kiil directly holds 48,233 Ordinary Shares, reflecting compensation-based share delivery rather than an open-market purchase or sale.

Positive

  • None.

Negative

  • None.
Insider KIIL HARRY SKIP
Role EVP & President Cardiovascular
Type Security Shares Price Value
Exercise Performance Share Unit 14,517 $0.00 $0.00
Exercise Ordinary Shares 15,195 $0.00 $0.00
Holdings After Transaction: Performance Share Unit — 0 shares (Direct); Ordinary Shares — 48,233 shares (Direct)
Footnotes (4)
  1. F1. Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026.
  2. F2. Includes 270 shares acquired through dividend reinvestment since the last report filed by the reporting person.
  3. F3. Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
  4. F4. The performance share units vested on April 24, 2026.
Ordinary shares acquired 15,195 shares Issued upon settlement of performance-vesting share units on May 26, 2026
Performance share units settled 14,517 units Each unit convertible into one Medtronic ordinary share
Post-transaction holdings 48,233 shares Direct Medtronic ordinary shares held after May 26, 2026 transaction
Grant date of performance units July 31, 2023 Original grant date of performance-vesting share units
Vesting date of performance units April 24, 2026 Vesting date before performance certification and settlement
performance-vesting share units financial
"Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023"
dividend reinvestment financial
"Includes 270 shares acquired through dividend reinvestment since the last report filed"
Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.
performance share unit financial
"Each performance share unit represents a contingent right to receive one share of Medtronic common stock"
A performance share unit (PSU) is a form of executive or employee pay that promises shares (or the cash value of shares) only if the company meets specific performance targets over a set period. Think of it like a bonus cheque that only arrives if the company hits agreed goals — it aligns managers’ rewards with business results and signals to investors how leadership is being incentivized to grow value over time.
contingent right financial
"Each performance share unit represents a contingent right to receive one share"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KIIL HARRY SKIP
(Last)(First)(Middle)
710 MEDTRONIC PARKWAY
(Street)
MINNEAPOLIS MINNESOTA 55432
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Medtronic plc [ MDT ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP & President Cardiovascular
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/26/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares05/26/2026M15,195(1)A$048,233(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Performance Share Unit(3)05/26/2026M14,517 (4) (4)Ordinary Shares14,517$00D
Explanation of Responses:
1. Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026.
2. Includes 270 shares acquired through dividend reinvestment since the last report filed by the reporting person.
3. Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
4. The performance share units vested on April 24, 2026.
Remarks:
/s/ Patricia Walesiewicz, attorney-in-fact05/28/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR